Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of MT-1303 in subjects with inflammatory bowel disease has completed. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• MT-1303

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Inflammatory Bowel Disease | Phase 1 | Status: COMPLETED